Reblozyl Prices, Coupons, Copay Cards & Patient Assistance
Reblozyl (luspatercept) is a member of the miscellaneous erythropoiesis agents drug class and is commonly used for Anemia, Beta Thalassemia, and Myelodysplastic Syndrome.
Reblozyl prices
Subcutaneous Powder For Injection
aamt 25 mg Reblozyl subcutaneous powder for injection from $4,400.86 for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $4,400.86 | $4,400.86 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
aamt 75 mg Reblozyl subcutaneous powder for injection from $13,182.52 for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $13,182.52 | $13,182.52 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Reblozyl Coupons, Copay Cards and Rebates
Reblozyl offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Reblozyl BMS Access Support Co-Pay Assistance Program
Eligible commercially insured patients may pay as little as $0 per dose patients must call 800-861-0048 to enroll.
- Applies to:
- Reblozyl
- Number of uses:
- per prescription per calendar year
Form more information phone: 800-861-0048 or Visit website
Patient Assistance & Copay Programs for Reblozyl
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Reblozyl (luspatercept-aamt) Injection; Subcutaneous
More information please phone: 800-675-8416 Visit website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Reblozyl (luspatercept-aamt) Injection; Subcutaneous
More information please phone: 866-316-7263 Visit website
Provider: Bristol Myers Squibb (BMS) Access Support
Eligibility requirements:- Contact program for details.
- Not disclosed
- Medically Necessary as determined by a Doctor
- Must be residing in the US or Puerto Rico
- *This program provides the screening for the Bristol-Myers Squibb Patient Assistance Foundation (BMSPAF) Oncology Patient Assistance Program. Co-payment assistance, patient support, and patient assistance programs are available for eligible patients. Please refer to the Enrollment Form to ensure the correct Fax number and address is used for your medication.
- Reblozyl (luspatercept-aamt) Injection; Subcutaneous
More information please phone: 800-861-0048 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Procrit
Procrit is a man-made protein used to treat anemia caused by chronic kidney disease, chemotherapy ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Dacogen
Dacogen (decitabine) is used to treat myelodysplastic syndromes (certain types of blood or bone ...
Inqovi
Inqovi (decitabine and cedazuridine) is used for the treatment of myelodysplastic syndromes (MDS) ...
Rytelo
Rytelo (imetelstat) is an injectable telomerase inhibitor that may be used to treat adults with ...
Onureg
Onureg (azacitidine) is used for the continued treatment of adult patients with acute myeloid ...
Cedazuridine/decitabine
Cedazuridine/decitabine is used for myelodysplastic syndrome
Ivosidenib
Ivosidenib is used for acute myeloid leukemia, biliary tract tumor, myelodysplastic syndrome
More about Reblozyl (luspatercept)
- Check interactions
- Compare alternatives
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous erythropoiesis agents
- Breastfeeding
- En español